Episode 47 – SGLT-2 Inhibitors in Heart Failure

Welcome back Rounds Table Listeners!

We are back today with our Classic Rapid Fire Podcast!

This week, Drs. John and Mike Fralick discuss two recent papers – one, a meta-analysis exploring the use of SGLT-2 inhibitors in heart failure, and the second investigating the efficacy of dapagliflozin according to frailty in heart failure. Two papers, here we go!

  1. Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction (0:00 – 7:20).

  2. SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials (7:20 – 15:45).

And for the Good Stuff:

Questions? Comments? Feedback? We’d love to hear from you! @roundstable

Leave a Comment

Your email address will not be published. Required fields are marked *

Republish this article

Republish this article on your website under the creative commons licence.

Learn more